DC Migration Study to Evaluate TReg Depletion In GBM Patients With and Without Varlilumab
Condition(s):GlioblastomaLast Updated:July 19, 2023Active, not recruiting
Hide Studies Not Open or Pending
Condition(s):GlioblastomaLast Updated:July 19, 2023Active, not recruiting
Condition(s):MelanomaLast Updated:February 6, 2024Completed
Condition(s):CD27 Expressing B-cell Malignancies for Example Hodgkin’s Lymphoma; Chronic Lymphocytic Leukemia; Mantle Cell Lymphoma; Marginal Zone B Cell Lymphoma); Any T-cell Malignancy; Solid Tumors (Metastatic Melanoma, Renal (Clear) Cell Carcinoma; Hormone-refractory Prostate Adenocarcinoma, Ovarian Cancer; Colorectal Adenocarcinoma, Non-small Cell Lung Cancer); Burkett’s Lymphoma; Primary Lymphoma of the Central Nervous SystemLast Updated:January 31, 2018Completed
Condition(s):Metastatic Distal Bile Duct Adenocarcinoma; Metastatic Gallbladder Carcinoma; Metastatic Intrahepatic Cholangiocarcinoma; Recurrent Distal Bile Duct Adenocarcinoma; Recurrent Gallbladder Carcinoma; Recurrent Intrahepatic Cholangiocarcinoma; Stage IV Distal Bile Duct Cancer AJCC v8; Stage IV Gallbladder Cancer AJCC v8; Stage IV Intrahepatic Cholangiocarcinoma AJCC v8; Unresectable Liver and Intrahepatic Bile Duct CarcinomaLast Updated:March 6, 2024Active, not recruiting
Condition(s):MelanomaLast Updated:September 6, 2019Terminated
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.